It’s become clear that pressure on research spending increased in the second quarter and will likely persist through fiscal ...

Earlier this morning, BD released its results for the second quarter of fiscal 2025. The press release and presentation can be accessed on the IR website at investors.bd.com. Leading today's call are ...

Gain insights into Becton, Dickinson's Q2 2025 earnings performance, growth strategies, U.S. manufacturing investment, and outlook on organic growth.

Shares of Becton Dickinson & Co. BDX shed 4.89% to $199.12 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 3.46% to 5,268 ...

Becton, Dickinson and Company BDX, popularly known as BD, is evaluating the divestment of its Life Sciences division as part of a broader strategic shift toward becoming a pure-play medtech company.

Looking at the universe of stocks we cover at Dividend Channel, in trading on Friday, shares of Becton, Dickinson & Co (Symbol: BDX) were yielding above the 2% mark based on its quarterly dividend ...

Becton, Dickinson and Company (NYSE:BDX) is a medical device company that develops and manufactures medical supplies, devices, laboratory equipment, and diagnostic products. The one-month return ...

Becton, Dickinson and Co. (BD) reported pay increases for some executives ... but employee compensation is kept secret in most cases. Medical Design & Outsourcing tracks and analyzes these pay figures ...

She said it was one of her most challenging design projects “because it was about meeting needs that were new to me,” but it was also one of her most enlightening. “The products were created ...